CYPRUMED GMBH has a total of 24 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals and biotechnology are ANHUI JINMA PHARMACEUTICAL CO LTD, ZIM LABORATORIES LTD and HAN SHENG PHARMTECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | United States | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | Israel | 2 | |
#8 | Brazil | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Singapore | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Föger Florian | 13 |
#2 | Werle Martin | 10 |
#3 | Foger Florian | 6 |
#4 | Florian Föger | 2 |
#5 | Foeger Florian | 1 |
Publication | Filing date | Title |
---|---|---|
US2021087250A1 | Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins | |
WO2018065634A1 | Pharmaceutical compositions for the nasal delivery of peptide or protein drugs | |
WO2017060500A1 | Pharmaceutical formulations for the oral delivery of peptide drugs | |
EP3006045A1 | Pharmaceutical formulations for the oral delivery of peptide or protein drugs |